After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, AMRX falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Amneal Pharmaceuticals Inc is $2.52B. A total of 1.55 million shares were traded on the day, compared to an average of 1.48M shares.
In the most recent transaction, BOYER ANDREW S sold 40,225 shares of AMRX for 7.85 per share on Aug 15 ’24. After the transaction, the Executive Vice President now owns 256,670 company shares. In a previous transaction on Aug 14 ’24, BOYER ANDREW S sold 22,486 shares at 7.81 per share. AMRX shares that Executive Vice President owns now total 296,895.
Among the insiders who sold shares, Shah Nikita disposed of 100,000 shares on Aug 14 ’24 at a per-share price of $7.75. This resulted in the Executive Vice President holding 291,666 shares of AMRX after the transaction. In another insider transaction, BOYER ANDREW S bought 70,000 shares at $7.80 per share on Aug 14 ’24.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, AMRX has a high of $8.15 and a low of $3.36.
As of this writing, AMRX has an earnings estimate of $0.13 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of $0.15 per share and a lower estimate of $0.12.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. AMRX’s latest balance sheet shows that the firm has $247.79M in Cash & Short Term Investments as of fiscal 2021. There were $2.88B in debt and $677.24M in liabilities at the time. Its Book Value Per Share was -$0.19, while its Total Shareholder’s Equity was $366.97M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMRX is Buy with a score of 4.20.
